Cited by

• Known drugs and small molecules in the battle for COVID-19 treatment.

  Panoutsopoulos AA. Panoutsopoulos AA. Genes Dis. 2020 Dec;7(4):528-534. doi: 10.1016/j.gendis.2020.06.007. Epub 2020 Jun 20. Genes Dis. 2020. PMID: 32837982 Free PMC article. Review.
• Transmission dynamics of SARS-CoV-2 variants in the Brazilian state of Pará.

  Pinho CT, Vidal AF, Negri Rocha TC, Oliveira RRM, da Costa Barros MC, Closset L, Azevedo-Pinheiro J, Braga-da-Silva C, Silva CS, Magalhães LL, do Carmo Pinto PD, Souza GBS, Dos Santos Vieira JR, Burbano RMR, de Sousa MS, de Souza JES, Nunes G, da Silva MB, da Costa PF, Salgado CG, Sousa RCM, Degrave WMS, Ribeiro-Dos-Santos Â, Oliveira G. Pinho CT, et al. Front Public Health. 2023 Jul 5;11:1186463. doi: 10.3389/fpubh.2023.1186463. eCollection 2023. Front Public Health. 2023. PMID: 37790714 Free PMC article.
• The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.

  Yang Y, Peng F, Wang R, Yange M, Guan K, Jiang T, Xu G, Sun J, Chang C. Yang Y, et al. J Autoimmun. 2020 May;109:102434. doi: 10.1016/j.jaut.2020.102434. Epub 2020 Mar 3. J Autoimmun. 2020. PMID: 32143990 Free PMC article. Review.
• Discovery of a novel benzimidazole conjugated quinazolinone derivative as a promising SARS-CoV-2 3CL protease inhibitor.

  Hue BTB, Nguyet Huong Giang H, Nguyen CQ, Chou FP, La Duc Thanh D, Tran Q, Hieu VT, Hoang Phuong Mai L, Lin HC, Wu TK. Hue BTB, et al. RSC Adv. 2024 Oct 24;14(46):33820-33829. doi: 10.1039/d4ra03267e. eCollection 2024 Oct 23. RSC Adv. 2024. PMID: 39450066 Free PMC article.
• Reconstruction of the unbinding pathways of noncovalent SARS-CoV and SARS-CoV-2 3CLpro inhibitors using unbiased molecular dynamics simulations.

  Noroozi Tiyoula F, Aryapour H. Noroozi Tiyoula F, et al. PLoS One. 2022 Feb 9;17(2):e0263251. doi: 10.1371/journal.pone.0263251. eCollection 2022. PLoS One. 2022. PMID: 35139108 Free PMC article.